Orchestra BioMed Ownership | Who Owns Orchestra BioMed?

Overview Forecast RevenueFinancials Chart

Orchestra BioMed Ownership Summary

Orchestra BioMed is owned by 5.09% institutional investors, 15.32% insiders, and 79.59% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares.

OBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Orchestra BioMed	5.09%	15.32%	79.59%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	8.31M	21.63%	$20.60M
Perceptive advisors	5.29M	13.79%	$13.13M
Vanguard group	1.48M	3.86%	$3.68M
Alyeska investment group	1.37M	3.56%	$3.39M
Pathstone	1.01M	2.62%	$2.49M
Affinity asset advisors	727.27K	1.89%	$1.80M
Blackrock funding, inc. /de	664.33K	1.73%	$1.65M
Knoll capital management	455.13K	1.19%	$421.16K
Price t rowe associates inc /md/	421.61K	1.10%	$1.05M
Geode capital management	386.80K	1.01%	$959.59K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lasry marc	60.87K	1.00%	$150.96K
Amh equity	166.00K	0.51%	$411.68K
Perceptive advisors	5.29M	0.38%	$13.13M
Rtw investments, lp	8.31M	0.25%	$20.60M
Knoll capital management	455.13K	0.23%	$421.16K
Dafna capital management	363.64K	0.22%	$901.82K
Knott david m jr	195.00K	0.20%	$483.60K
Affinity asset advisors	727.27K	0.16%	$1.80M
Alyeska investment group	1.37M	0.01%	$3.39M
Pathstone	1.01M	0.01%	$2.49M

Top Buyers

Holder	Shares	% Assets	Change
Alyeska investment group	1.37M	0.01%	1.37M
Pathstone	1.01M	0.01%	1.01M
Affinity asset advisors	727.27K	0.16%	727.27K
Perceptive advisors	5.29M	0.38%	700.00K
Dafna capital management	363.64K	0.22%	363.64K

Top Sellers

Holder	Shares	% Assets	Change
Goldman sachs group	23.63K	-	-73.21K
Bank of new york mellon	-	-	-52.49K
Marshall wace, llp	-	-	-49.47K
Hightower advisors	18.27K	0.00%	-48.23K
Y-intercept (hong kong)	-	-	-45.45K

New Positions

Holder	Shares	% Assets	Change	Value
Alyeska investment group	1.37M	0.01%	1.37M	$3.39M
Pathstone	1.01M	0.01%	1.01M	$2.49M
Affinity asset advisors	727.27K	0.16%	727.27K	$1.80M
Dafna capital management	363.64K	0.22%	363.64K	$901.82K
Amh equity	166.00K	0.51%	166.00K	$411.68K

Sold Out

Holder	Change
Eversource wealth advisors	-1.00
True wealth design	-6.00
Gamma investing	-101.00
Sierra ocean	-119.00
Russell investments group	-193.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	10	-82.76%	1,953,498	-89.23%	5	0.23%	4	-88.57%	3	-81.25%
Jun 30, 2025	58	5.45%	18,134,637	-4.51%	47	1.91%	35	52.17%	16	-11.11%
Mar 31, 2025	54	8.00%	18,940,149	1.07%	49	2.00%	22	-31.25%	18	157.14%
Dec 31, 2024	52	10.64%	19,199,487	0.91%	51	2.00%	34	25.93%	7	-22.22%
Sep 30, 2024	47	2.17%	19,025,949	33.83%	50	3.21%	27	-10.00%	9	28.57%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 14, 2025	Hochman David P	See Remarks	Buy	$20.35K
Sep 19, 2025	Aryeh Jason	-	Buy	$2.45K
Aug 25, 2025	Fain Eric S	-	Buy	$15.03K
Aug 25, 2025	Sherman Darren	See Remarks	Buy	$7.86K
Aug 21, 2025	Hochman David P	See Remarks	Buy	$14.94K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	-
2025 Q3	9	-
2025 Q2	2	1
2025 Q1	-	-
2024 Q4	3	-

OBIO Ownership FAQ

Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 5.09%, followed by 15.32% insiders and 79.59% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 45.22%, which Orchestra BioMed falls below.

Who owns the most shares of Orchestra BioMed?

Orchestra BioMed’s largest shareholders are Rtw investments, lp (8.31M shares, 21.63%), Perceptive advisors (5.29M shares, 13.79%), and Vanguard group (1.48M shares, 3.86%). Together, they hold 39.28% of Orchestra BioMed’s total shares outstanding.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Lasry marc is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 1.00% of its assets in 60.87K Orchestra BioMed shares, valued at 150.96K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools